The Path to Optimal Black Maternal Heart Health: Comparing Two CVD Risk Reduction Interventions (Change of HEART)
Launched by TEMPLE UNIVERSITY · Aug 11, 2022
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
The Change of HEART trial is focused on improving heart health for Black women during and after pregnancy. The study aims to find better ways to reduce the risk of heart disease and related health issues, like high blood pressure and obesity, which can affect pregnant women. By involving the community and understanding the social factors that contribute to these health disparities, the trial hopes to make a positive impact on the lives of Black mothers.
To be part of this study, women must be at least 18 years old, have a body mass index (BMI) of 30 or higher (which is a measure of obesity), or have high blood pressure. They should also be less than 24 weeks pregnant and own a smartphone. Participants can expect to work with a supportive team that focuses on their unique health needs and experiences. This trial is currently recruiting, so if you or someone you know fits the criteria, it could be a great opportunity to help improve heart health for Black mothers in the community.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • age ≥18 years
- • baseline BMI ≥30 kg/m2 and/or diagnosis of HTN (≥130/80 x 2)
- • gestational age \<24 weeks by last menstrual period
- • smartphone ownership
- • self-identification as Black or African American
About Temple University
Temple University is a leading academic institution located in Philadelphia, Pennsylvania, renowned for its commitment to research and innovation in the health sciences. As a clinical trial sponsor, Temple University leverages its extensive resources, including a diverse pool of participants and cutting-edge facilities, to advance medical knowledge and improve patient care. The university's clinical research initiatives are driven by a multidisciplinary team of experts dedicated to conducting high-quality studies that address critical health issues and contribute to the development of novel therapies. Through its partnerships with local and global organizations, Temple University aims to enhance the translation of research findings into practical applications that benefit communities and advance public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Patients applied
Trial Officials
Sharon J Herring, MD, MPH
Principal Investigator
Temple University, Philadelphia, Pennsylvania, United States, 19140
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials